- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.11: 2 residues within 4Å:- Chain A: D.185, N.186
No protein-ligand interaction detected (PLIP)NAG.13: 2 residues within 4Å:- Chain B: D.185, N.186
No protein-ligand interaction detected (PLIP)NAG.15: 2 residues within 4Å:- Chain C: D.185, N.186
No protein-ligand interaction detected (PLIP)NAG.17: 2 residues within 4Å:- Chain D: D.185, N.186
No protein-ligand interaction detected (PLIP)NAG.20: 2 residues within 4Å:- Chain E: D.185, N.186
No protein-ligand interaction detected (PLIP)- 5 x U9Q: 1-(3-chlorophenyl)sulfonyl-4-piperazin-1-yl-pyrrolo[3,2-c]quinoline(Non-covalent)
U9Q.12: 13 residues within 4Å:- Chain A: D.146, I.148, W.167, R.169, Y.230, R.273, D.281, S.283, I.284
- Chain B: S.259, W.260, I.305, Y.311
6 PLIP interactions:2 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:I.305, A:I.148, A:W.167, A:R.169
- Hydrogen bonds: B:W.260
- pi-Stacking: A:Y.230
U9Q.14: 13 residues within 4Å:- Chain B: D.146, I.148, W.167, R.169, Y.230, R.273, D.281, S.283, I.284
- Chain C: S.259, W.260, I.305, Y.311
6 PLIP interactions:4 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:I.148, B:W.167, B:R.169, C:I.305
- pi-Stacking: B:Y.230
- Hydrogen bonds: C:W.260
U9Q.16: 13 residues within 4Å:- Chain C: D.146, I.148, W.167, R.169, Y.230, R.273, D.281, S.283, I.284
- Chain D: S.259, W.260, I.305, Y.311
6 PLIP interactions:4 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:I.148, C:W.167, C:R.169, D:I.305
- pi-Stacking: C:Y.230
- Hydrogen bonds: D:W.260
U9Q.18: 13 residues within 4Å:- Chain D: D.146, I.148, W.167, R.169, Y.230, R.273, D.281, S.283, I.284
- Chain E: S.259, W.260, I.305, Y.311
6 PLIP interactions:4 interactions with chain D, 2 interactions with chain E- Hydrophobic interactions: D:I.148, D:W.167, D:R.169, E:I.305
- pi-Stacking: D:Y.230
- Hydrogen bonds: E:W.260
U9Q.19: 12 residues within 4Å:- Chain A: S.259, W.260, I.305, Y.311
- Chain E: D.146, I.148, W.167, R.169, Y.230, R.273, D.281, S.283
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain E- Hydrophobic interactions: A:I.305, E:I.148, E:W.167, E:R.169
- Hydrogen bonds: A:W.260
- pi-Stacking: E:Y.230
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grychowska, K. et al., Superiority of the Triple-Acting 5-HT 6 R/5-HT 3 R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT 6 R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats. J.Med.Chem. (2023)
- Release Date
- 2023-10-11
- Peptides
- 5-hydroxytryptamine receptor 3A: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 5 x U9Q: 1-(3-chlorophenyl)sulfonyl-4-piperazin-1-yl-pyrrolo[3,2-c]quinoline(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grychowska, K. et al., Superiority of the Triple-Acting 5-HT 6 R/5-HT 3 R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT 6 R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats. J.Med.Chem. (2023)
- Release Date
- 2023-10-11
- Peptides
- 5-hydroxytryptamine receptor 3A: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.